ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaarExtrovis AG
Extrovis AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Extrovis AG is a global Contract Research, Development & Manufacturing Organization (CRDMO) that develops and manufactures complex specialty therapeutics, including sterile antibiotics, oncology and cytotoxic formulations, and female hormone products. The company provides R&D, regulated-market manufacturing (USFDA, EU‑GMP) and supply‑chain and regulatory support across drug substances and finished dosage forms.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentChemical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Extrovis AG

Pharmaceutical Industry
✓ Offered4
API manufacturing
Sterile cephalosporins, highly potent monobactams, advanced intermediates and controlled substances; with aseptic processing, containment, scale-up, purification and cGMP-compliant production.
Pharmaceutical manufacturing
Oncology solid dosage forms, injectables, topicals and oral liquids as well as cephalosporins, female hormones and general topicals; with development, tech transfer, scale-up, fill-finish, packaging and commercial supply.
Research and Development
Development of new and differentiated FDFs, APIs and intermediates; in addition, drug-device combinations, advanced delivery systems, peptides and sterile injectables.
CDMO partnership and tech transfer
Long-term development and manufacturing partnerships with tech transfer, scale-up, commercial supply, lifecycle management and support for regulated markets.
Trust & reputation

ranQ Trust Score of Extrovis AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Extrovis AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Extrovis AG scores 90.0 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.86.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.96.07%
Extrovis AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Extrovis AG scores 51.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.51.44%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Extrovis AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Extrovis AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Extrovis AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Extrovis AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Extrovis AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Bahnhof-Park 4
6340 Baar

At a glance

Legal form
Corporation
UID
CHE-280.317.373
Founded
2016 · 10 years
Last commercial register change
September 27, 2024
Employees
101 to 500
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    DD
    DIF, Die Ideenfabrik AG
    Baar
    SA
    Scalepharm AG
    Baar
    AS
    Arxada Switzerland AG
    Rotkreuz
    RP
    Rapid Pharma Development GmbH
    Unterägeri
    GS
    G&L Scientific (Schweiz) GmbH
    Zug
    KF
    KUB Foundation
    Zug
    IS
    Insmed Switzerland GmbH
    Zug
    DS
    DEFI Stiftung
    Zug